CN Patent

CN106365986B — 化合物及其制备方法和在合成布瓦西坦中的用途

Assigned to SUZHOU PENGXU PHARMATECH Co Ltd · Expires 2019-01-08 · 7y expired

What this patent protects

本申请提供一种式II和IV化合物。本申请还提供式II化合物用于合成布瓦西坦的用途以及合成方法。本申请所述方法涉及的原料易得且价格便宜，可制备出高光学纯度的布瓦西坦。

USPTO Abstract

本申请提供一种式II和IV化合物。本申请还提供式II化合物用于合成布瓦西坦的用途以及合成方法。本申请所述方法涉及的原料易得且价格便宜，可制备出高光学纯度的布瓦西坦。

Drugs covered by this patent

Patent Metadata

Patent number
CN106365986B
Jurisdiction
CN
Classification
—
Expires
2019-01-08
Drug substance claim
No
Drug product claim
No
Assignee
SUZHOU PENGXU PHARMATECH Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.